… that male and female breast cancer differ in their molecular landscapes. In this systematic
review, we consolidated all existing prognostic biomarker data in male breast cancer spanning …

… underlying gene copy number alterations and we evaluated … Chromosome 17 copy numbers
that are detected by FISH can … in breast cancer patients, even without concurrent ERBB2 …

… SPEC ERBB2 probe specific for the chromosomal region … We evaluated the HER2/neu gene
amplification status by D-… the discrepancy in evaluating chromosome 17 abnormalities in our …

… alone (eg, chromosome 17 ERBB2 gene locus), resulting in … most common abnormalities
in GEA and breast cancers, none … the value of CMA in GEA evaluation. Our study calls for the …

… receptor 2 (HER2) ERBB2 gene has been at the forefront of … HER2 assessment in breast
cancer can be made using a variety of … by using alternative chromosome 17 reference genes: …

… diagnostic evaluation of HER2/neu status in breast cancer patients… been characterized by
many recurrent genetic abnormalities … ratio which is able to exclude chromosome 17 polysomy.…

… gene, located on chromosome 17, is a suppressor gene that … of developing breast cancer
regardless of menopausal status. … These mutations, including NF1 loss and ERBB2 activating …

… To characterize these abnormalities, a review of the literature has … as being at low risk for
breast cancer in this review. … for Her-2/neu (c-erbB2) protein overexpression. Rohan et al 83 …

… in breast cancer can be an effective therapeutic approach for developing novel drugs. This
systematic review discusses gene mutations linked to breast cancer, … status/quality of life [40]. …

… of BC, we evaluated the efficacy of attMIL pipelines in predicting ERα and PR status in both
… which could be predictive of the hormone receptor status of the tumor in H&E-stained slides. …